文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

能量密集型与常规肠内营养在重症患者中的比较

Energy-Dense versus Routine Enteral Nutrition in the Critically Ill.
PubMed 文献 · N Engl J Med · 2018-10-22
一句话结论机械通气成人中,能量密集型(1.5 kcal/ml)肠内营养较常规(1.0 kcal/ml)并未提高90天生存率。

该多中心、双盲、随机试验纳入澳大利亚和新西兰46个ICU中接受机械通气的成人,比较能量密集型(1.5 kcal/ml)与常规(1.0 kcal/ml)肠内营养,均按1 ml/kg理想体重/小时给药,于营养支持开始或开始后12小时内启动,持续至ICU内最长28天。主要终点为90天全因死亡。改良意向性分析共3957例(1.5-kcal组1971例,1.0-kcal组1986例),两组肠内营养输注量相似,但1.5-kcal组日均热量为1863±478 kcal,1.0-kcal组为1262±313 kcal(均差601 kcal/天,95%CI 576–626)。90天时1.5-kcal组1948例中523例(26.8%)死亡,1.0-kcal组1966例中505例(25.7%)死亡(RR 1.05,95%CI 0.94–1.16,P=0.41)。结论:能量密集型肠内营养的90天生存率不高于常规肠内营养。

要点

  • 机械通气成人中,能量密集型(1.5 kcal/ml)较常规(1.0 kcal/ml)肠内营养的90天死亡率无显著差异(26.8% vs 25.7%;RR 1.05,95%CI 0.94–1.16,P=0.41)。
  • 两组肠内营养输注量相似,但1.5-kcal组日均热量1863±478 kcal,1.0-kcal组1262±313 kcal(均差601 kcal/天,95%CI 576–626)。
  • 较高热量 delivery 未影响生存时间、器官支持使用、存活且离开ICU和医院的 days 或无器官支持天数,也未影响感染并发症或不良事件发生率。
  • 七个预设亚组结果相似。
  • 作者结论:能量密集型肠内营养的90天生存率不高于常规肠内营养。

适用人群与场景

  • 澳大利亚和新西兰46个ICU中接受机械通气的成人。

处置流程与药物剂量

  • 能量密集型肠内营养:1.5 kcal/ml,按1 ml/kg理想体重/小时给药,于营养支持开始或开始后12小时内启动,持续至ICU内最长28天。
  • 常规肠内营养:1.0 kcal/ml,按1 ml/kg理想体重/小时给药,于营养支持开始或开始后12小时内启动,持续至ICU内最长28天。

研究设计与关键结果

  • 多中心、双盲、随机试验,46个ICU,改良意向性分析3957例(1.5-kcal组1971例,1.0-kcal组1986例)。
  • 主要终点90天全因死亡:1.5-kcal组1948例中523例(26.8%)vs 1.0-kcal组1966例中505例(25.7%),RR 1.05(95%CI 0.94–1.16),P=0.41。
  • 日均热量:1.5-kcal组1863±478 kcal vs 1.0-kcal组1262±313 kcal,均差601 kcal/天(95%CI 576–626)。
  • 七个预设亚组结果相似;较高热量未影响生存时间、器官支持使用、存活且离开ICU和医院的天数或无器官支持天数、感染并发症或不良事件发生率。

证据类型、等级与局限

  • 证据类型:多中心、双盲、随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在机械通气的成人ICU患者中,使用能量密集型(1.5 kcal/ml)肠内营养较常规(1.0 kcal/ml)并未提高90天生存率;作者结论为能量密集型肠内营养的90天生存率不高于常规肠内营养。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effect of delivering nutrition at different calorie levels during critical illness is uncertain, and patients typically receive less than the recommended amount.

METHODS: We conducted a multicenter, double-blind, randomized trial, involving adults undergoing mechanical ventilation in 46 Australian and New Zealand intensive care units (ICUs), to evaluate energy-dense (1.5 kcal per milliliter) as compared with routine (1.0 kcal per milliliter) enteral nutrition at a dose of 1 ml per kilogram of ideal body weight per hour, commencing at or within 12 hours of the initiation of nutrition support and continuing for up to 28 days while the patient was in the ICU. The primary outcome was all-cause mortality within 90 days.

RESULTS: There were 3957 patients included in the modified intention-to-treat analysis (1971 in the 1.5-kcal group and 1986 in the 1.0-kcal group). The volume of enteral nutrition delivered during the trial was similar in the two groups; however, patients in the 1.5-kcal group received a mean (±SD) of 1863±478 kcal per day as compared with 1262±313 kcal per day in the 1.0-kcal group (mean difference, 601 kcal per day; 95% confidence interval [CI], 576 to 626). By day 90, a total of 523 of 1948 patients (26.8%) in the 1.5-kcal group and 505 of 1966 patients (25.7%) in the 1.0-kcal group had died (relative risk, 1.05; 95% CI, 0.94 to 1.16; P=0.41). The results were similar in seven predefined subgroups. Higher calorie delivery did not affect survival time, receipt of organ support, number of days alive and out of the ICU and hospital or free of organ support, or the incidence of infective complications or adverse events.

CONCLUSIONS: In patients undergoing mechanical ventilation, the rate of survival at 90 days associated with the use of an energy-dense formulation for enteral delivery of nutrition was not higher than that with routine enteral nutrition. (Funded by National Health and Medical Research Institute of Australia and the Health Research Council of New Zealand; TARGET ClinicalTrials.gov number, NCT02306746 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Chapman M, Peake SL, Bellomo R, et al. Energy-Dense versus Routine Enteral Nutrition in the Critically Ill. N Engl J Med. 2018. PMID: 30346225. doi:10.1056/NEJMoa1811687

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。